Carotid artery disease causes up to 30% of all strokes, but severely calcified lesions can make treatment quite complex. The hope is that IVL can be as successful in this area as it has been in the treatment of coronary and peripheral artery disease.
Targeted interventions could help reduce pre-test anxiety, improve the physical screening experience, and address structural barriers in underserved settings.
Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.
As the use of AI in imaging continues to grow, it’s “become clear" that real world performance of these products can defer from premarket testing, experts note.
In other news, the University of Nebraska Medical Center has named Ryan Lee, MD, MBA, as its next chair of radiology, while ASRT has elected new board members.
Carotid artery disease causes up to 30% of all strokes, but severely calcified lesions can make treatment quite complex. The hope is that IVL can be as successful in this area as it has been in the treatment of coronary and peripheral artery disease.
![Performing transcatheter aortic valve replacement (TAVR) with the J-Valve transcatheter heart valve (THV) may help limit the risk of coronary artery obstruction (CAO) in high-risk patients, according to a new study published in Clinical Interventions in Aging.[1]](/sites/default/files/styles/stack_views/public/2024-10/screenshot_2024-10-01_at_2.16.21_pm.png.webp?itok=qOxNPyOr)
